Header Logo
Last Name

Search Results (16)

Click the Why column to see why an item matched the search.

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.Academic Article Why?
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.Academic Article Why?
Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.Academic Article Why?
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma.Academic Article Why?
MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.Academic Article Why?
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma.Academic Article Why?
Evaluation of Rhodiola crenulata on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line.Academic Article Why?
MDM2 as a critical effector of the MYCN oncogene in tumorigenesis.Academic Article Why?
MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis.Academic Article Why?
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.Academic Article Why?
MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.Academic Article Why?
Redefining functional MYCN gene signatures in neuroblastoma.Academic Article Why?
Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish.Academic Article Why?
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.Academic Article Why?
A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.Academic Article Why?
Per Page    Page  of 2last Nextnext
Search Criteria
  • MYCN
Filter by Type